Building on these findings, clinical trials are now investigating these therapeutic applications more systematically, including studies examining incretin agonists for both alcohol consumption and alcohol-related disorders (ClinicalTrials.gov identifiers: NCT06546384, NCT06409130, NCT07046819, NCT05891587, NCT05895643, NCT06015893, NCT05892432, NCT06939088, NCT06727331, and NCT06994338)
Pharmacists Perspective Faryal Faisal, PharmD My most important advice for patients starting any GLP-1 medication: do not restrict foods before you need to
Distributing protein across three to four meals enhances muscle protein synthesis more effectively than consuming the same total amount in one or two meals
Data-backed habits help you stay informed and motivated, and give your doctor a clearer picture of how your treatment is going
Medically necessary diagnostic services
A plateau refers to a period where weight loss slows significantly or stops temporarily despite continued medication adherence and lifestyle efforts